These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24697987)

  • 1. Epoetin in the 'untransfusable' anaemic patient: a retrospective case series and systematic analysis of literature case reports.
    Heh-Foster AM; Naber M; Pai MP; Lesar TS
    Transfus Med; 2014 Aug; 24(4):204-8. PubMed ID: 24697987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.
    Case AS; Rocconi RP; Kilgore LC; Barnes MN
    Gynecol Oncol; 2006 Jun; 101(3):499-502. PubMed ID: 16406064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
    Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
    J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: a retrospective cohort study.
    Nurko S; Spirko R; Law A; Dennis VW
    Clin Ther; 2007 Sep; 29(9):2010-21. PubMed ID: 18035200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.
    Cianciaruso B; Ravani P; Barrett BJ; Levin A;
    J Nephrol; 2008; 21(6):861-70. PubMed ID: 19034870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
    Wilhelm-Leen ER; Winkelmayer WC
    Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa.
    Debus J; Drings P; Baurecht W; Angermund R
    Radiother Oncol; 2014 Jul; 112(1):23-9. PubMed ID: 25129551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
    Mark TL; McKenzie RS; Fastenau J; Piech CT
    Curr Med Res Opin; 2005 Sep; 21(9):1347-54. PubMed ID: 16197652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change.
    Beliaev AM; Allen SJ; Milsom P; Nand P; Smith WM; Bergin CJ
    Blood Transfus; 2018 Jan; 16(1):53-62. PubMed ID: 27893353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice.
    Pujade-Lauraine E; Richard AJ; Sapède C; Hayward C
    Oncol Rep; 2005 Oct; 14(4):1037-44. PubMed ID: 16142369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
    Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
    Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.
    Mohammadpour AH; Nazemian F; Khaiat MH; Tafaghodi M; Salari P; Charkazi S; Naghibi M; Shamsara J
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):73-8. PubMed ID: 24434385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy.
    Tunceli O; Bailey RA; Stephenson JJ; Singer J
    J Oncol Pharm Pract; 2013 Dec; 19(4):305-14. PubMed ID: 23235918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of subcutaneous epoetin-zeta on anemia in renal transplant recipients: a single-center experience.
    Sabbatini M; Vitale S; Garofalo G; Torino M; Gallo R; Carrano R; Federico S
    Transplant Proc; 2014 Sep; 46(7):2238-40. PubMed ID: 25242760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy.
    Aapro MS; Dale DC; Blasi M; Sarokhan B; Ahmed F; Woodman RC
    Support Care Cancer; 2006 Dec; 14(12):1184-94. PubMed ID: 16758175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study.
    Duce L; Cooter ML; McCartney SL; Lombard FW; Guinn NR
    Anesth Analg; 2018 Aug; 127(2):490-495. PubMed ID: 28857800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
    Agarwal R; Davis JL; Smith L
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):98-104. PubMed ID: 18045859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.